Polynucleotide treatment is a **regenerative injectable therapy** made from purified DNA fragments, usually sourced from salmon or trout. Sounds odd at first, I know. The idea is that these DNA chains act like biological messengers. Once injected into the skin, they bind water, reduce inflammation, and signal fibroblasts to repair tissue and improve skin quality over time. Its not filler. It doesnt push or lift. Its more like giving the skin better instructions and raw materials so it can heal itself. Brands youll hear a lot in the UK are **Plinest**, **PhilArt**, and **Nucleofill**. ([aestheticsjournal.com](https://aestheticsjournal.com/feature/polynucleotides-the-regenerative-injectable))
Our dataset currently has 16 clinic(s), with approximately 359 reviews and an average rating of 4.642857143.
Medical Infrastructure:
- Primary care led system under Health and Social Care (HSC) Northern Ireland
- Acute services linked to South West Acute Hospital (Western Health and Social Care Trust)
- Presence of NHS GP practices and independent aesthetic providers
Local Aethetics Market:
- Developing but saturated at micro-market scale
- Strong nurse-led aesthetic presence
- Avoid alcohol and blood-thinning meds 2448 hours before if advised.
- Arrive with clean skin, no makeup on the treatment area.
- Plan a low-key day afterward in case of swelling.
- Have realistic expectations. This is a slow burn treatment.
Most protocols suggest **23 sessions spaced 24 weeks apart**.
Generally well tolerated with a low complication rate.Temporary swelling, redness, or small lumps at injection sites are common.Products are purified and biocompatible. ([aestheticsjournal.com](https://aestheticsjournal.com/feature/polynucleotides-the-regenerative-injectable))
Most people describe it as mild to moderate discomfort. Numbing cream is usually used, especially for sensitive areas like under eyes.
- Medical qualification with injectable training.
- Specific education in regenerative injectables.
- Strong anatomical knowledge, especially for eye area treatments.
- Professional indemnity insurance.
There are no dedicated NICE guidelines specifically for polynucleotides. MHRA regulates the products used, and practitioners are expected to follow general injectable and aesthetic medicine safety standards. Clinical use is guided by emerging evidence and professional consensus rather than formal national protocols.
Local regulatory authority:
- Regulation and Quality Improvement Authority (RQIA) for Northern Ireland
- General Medical Council (GMC) for doctors
- Nursing and Midwifery Council (NMC) for nurse prescribers
Private insurance usage locally:
- Limited use of private insurance for aesthetics
- Dermatology may be privately self-funded or NHS-referred depending on indication
Cosmetic finance availability:
- Primarily pay-per-treatment
- Limited evidence of structured third-party finance penetration compared to major UK cities
- Medical qualification with injectable training.
- Specific education in regenerative injectables.
- Strong anatomical knowledge, especially for eye area treatments.
- Professional indemnity insurance.
- A medically qualified injector who understands facial anatomy properly.
- Someone who explains that this is about skin quality, not volume.
- Clear consent process and discussion of alternatives.
- Experience treating delicate areas like the under eyes. ([harleyacademy.com](https://www.harleyacademy.com/aesthetic-courses/polynucleotides/))
Current average rating citywide: 4.642857143